, Tracking Stock Market Picks
Enter Symbol:
Valeant Pharmaceuticals International Inc (VRX) [hlAlert]

up 558.16 %

Valeant Pharmaceuticals International Inc (VRX) rated Buy with price target $75 by Stifel Nicolaus

Posted on: Thursday,  Oct 11, 2012  8:25 AM ET by Stifel Nicolaus

Stifel Nicolaus rated Buy Valeant Pharmaceuticals International Inc (NYSE: VRX) on 10/11/2012. Previously Stifel Nicolaus rated Buy Valeant Pharmaceuticals International Inc (NYSE: VRX)
on 01/07/2011., when the stock price was $35.69. Since then, Valeant Pharmaceuticals International Inc has gained 558.17% as of 01/06/2016's recent price of $234.90.
If you would have followed the previous Stifel Nicolaus's recommendation on VRX, you would have gained 558.16% of your investment in 1825 days.

Biovail Corporation (Biovail) is a specialty pharmaceutical company that applies advanced drug-delivery technologies to improve the clinical effectiveness of medicines. The Company is engaged in the formulation, clinical testing, registration, manufacture and commercialization of pharmaceutical products. The Company has various research and development, clinical research, manufacturing and commercial operations located in Barbados, Canada, the United States and Puerto Rico. Its main therapeutic areas of focus are central nervous system (CNS) disorders, pain management and cardiovascular disease. The primary markets for its products are the United States and Canada. On September 16, 2008, Biovail acquired Prestwick Pharmaceuticals, Inc.

Stifel Nicolaus research focuses on all market caps, but is a leader in small- and mid-cap research. The department is staffed predominately with industry professionals from outside Wall Street. In fact, approximately 50% of its analysts have hands-on work experience in the industry that they research. Stifel Nicolaus believes industry experience, its opportunistic approach, and broad market cap coverage drive excess returns and its award-winning franchise.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/11/2012 8:25 AM Buy
55.85 75.00
as of 12/31/2012
1 Week down  -1.10 %
1 Month up  8.54 %
3 Months up  8.05 %
1 YTD up  27.90 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/18/2011 10:25 AM Buy
55.17 60.00
1/7/2011 9:25 AM Buy
35.69 40.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy